1. Home
  2. CYTH vs JOB Comparison

CYTH vs JOB Comparison

Compare CYTH & JOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • JOB
  • Stock Information
  • Founded
  • CYTH 1990
  • JOB 1893
  • Country
  • CYTH United States
  • JOB United States
  • Employees
  • CYTH N/A
  • JOB N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • JOB Diversified Commercial Services
  • Sector
  • CYTH Health Care
  • JOB Consumer Discretionary
  • Exchange
  • CYTH Nasdaq
  • JOB Nasdaq
  • Market Cap
  • CYTH 26.2M
  • JOB 24.7M
  • IPO Year
  • CYTH N/A
  • JOB N/A
  • Fundamental
  • Price
  • CYTH $0.80
  • JOB $0.26
  • Analyst Decision
  • CYTH Buy
  • JOB
  • Analyst Count
  • CYTH 3
  • JOB 0
  • Target Price
  • CYTH $0.95
  • JOB N/A
  • AVG Volume (30 Days)
  • CYTH 52.2K
  • JOB 10.9M
  • Earning Date
  • CYTH 03-17-2025
  • JOB 02-11-2025
  • Dividend Yield
  • CYTH N/A
  • JOB N/A
  • EPS Growth
  • CYTH N/A
  • JOB N/A
  • EPS
  • CYTH N/A
  • JOB N/A
  • Revenue
  • CYTH $870,725.00
  • JOB $116,483,000.00
  • Revenue This Year
  • CYTH N/A
  • JOB $43.94
  • Revenue Next Year
  • CYTH $24.49
  • JOB N/A
  • P/E Ratio
  • CYTH N/A
  • JOB N/A
  • Revenue Growth
  • CYTH N/A
  • JOB N/A
  • 52 Week Low
  • CYTH $0.55
  • JOB $0.20
  • 52 Week High
  • CYTH $2.12
  • JOB $0.51
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 70.05
  • JOB 56.94
  • Support Level
  • CYTH $0.76
  • JOB $0.22
  • Resistance Level
  • CYTH $0.86
  • JOB $0.30
  • Average True Range (ATR)
  • CYTH 0.07
  • JOB 0.05
  • MACD
  • CYTH 0.03
  • JOB 0.01
  • Stochastic Oscillator
  • CYTH 92.58
  • JOB 21.61

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

Share on Social Networks: